{"id":8142,"date":"2025-04-26T05:00:00","date_gmt":"2025-04-26T02:00:00","guid":{"rendered":"https:\/\/elika.app\/hamile-kadin-bebek\/?p=8142"},"modified":"2025-04-24T14:47:42","modified_gmt":"2025-04-24T11:47:42","slug":"tek-doz-hpv-asisi-yeterli-mi","status":"publish","type":"post","link":"https:\/\/elika.app\/hamile-kadin-bebek\/2025\/04\/26\/tek-doz-hpv-asisi-yeterli-mi\/","title":{"rendered":"Tek Doz HPV A\u015f\u0131s\u0131 Yeterli Mi?"},"content":{"rendered":"\n

Rahim a\u011fz\u0131 kanserinin nedeni nedir?<\/strong><\/p>\n\n\n\n

Rahim a\u011fz\u0131 kanseri 2000\u2019li y\u0131llar\u0131n gelmesiyle beraber \u00f6nemli bir konuma ula\u015ft\u0131. \u00c7\u00fcnk\u00fc Human Papilloma Vir\u00fcs\u00fc (HPV) ad\u0131 verilen ve 200\u2019den fazla tipi bulunan vir\u00fcs\u00fcn baz\u0131 tiplerinin yaratt\u0131\u011f\u0131 kal\u0131c\u0131 enfeksiyonun rahim a\u011fz\u0131 kanserine neden oldu\u011fu \u00f6\u011frenildi. Kal\u0131c\u0131 HPV enfeksiyonu rahim a\u011fz\u0131 kanser \u00e7e\u015fitlerinin %95\u2019ten fazlas\u0131n\u0131n etkenidir.<\/p>\n\n\n\n

HPV ile ilgili bu durum hem rahim a\u011fz\u0131 kanseri taramas\u0131nda hem de bu vir\u00fcse kar\u015f\u0131 ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n sa\u011flanmas\u0131 konusunda al\u0131\u015fkanl\u0131klar\u0131n de\u011fi\u015fmesine yol a\u00e7t\u0131. G\u00fcn\u00fcm\u00fczde HPV a\u015f\u0131lar\u0131 ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n sa\u011flanmas\u0131 konusunda ciddi etkinlik sunmaktad\u0131r.<\/p>\n\n\n\n

HPV a\u015f\u0131s\u0131n\u0131n uygulanma yayg\u0131nl\u0131\u011f\u0131 nas\u0131ld\u0131r?<\/strong><\/p>\n\n\n\n

A\u015f\u0131lama yoluyla bir kanserin \u00f6nlenebilmesi fikri D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6) gibi koruyucu sa\u011fl\u0131k hizmetlerinin y\u00f6nlendirildi\u011fi kurumlar a\u00e7\u0131s\u0131ndan da ciddi anlamda bir motivasyon kayna\u011f\u0131 oldu. Bu hususta rahim a\u011fz\u0131 kanserinin s\u0131kl\u0131\u011f\u0131 ve yayg\u0131nl\u0131\u011f\u0131n\u0131 azaltabilmek ya da rahim a\u011fz\u0131 kanserini tamamen yok edebilmek i\u00e7in DS\u00d6 15 ya\u015f alt\u0131 k\u0131z \u00e7ocuklar\u0131nda a\u015f\u0131lanma oran\u0131n\u0131n y\u00fczde 90 ve \u00fczerinde olmas\u0131n\u0131 hedefledi. Ancak, gelinen noktada mevcut durum belirlenen y\u00fczde 90 hedefinin \u00e7ok uza\u011f\u0131nda yakla\u015f\u0131k y\u00fczde 13-15 seviyelerinde kald\u0131.<\/p>\n\n\n\n

HPV a\u015f\u0131s\u0131n\u0131n maliyeti y\u00fcksek midir?<\/strong><\/p>\n\n\n\n

D\u00fc\u015f\u00fck a\u015f\u0131lanma oranlar\u0131n\u0131n temel sebebi bir\u00e7ok \u00fclkede a\u015f\u0131lanman\u0131n ulusal a\u015f\u0131lama takviminde yer bulamamas\u0131 ve buna ba\u011fl\u0131 olarak ortaya \u00e7\u0131kan y\u00fcksek a\u015f\u0131 maliyetidir. Rahim a\u011fz\u0131 kanseri \u00f6zellikle ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin daha d\u00fc\u015f\u00fck oldu\u011fu iyi beslenemeyen bir ba\u015fka ifadeyle d\u00fc\u015f\u00fck sosyoekonomik d\u00fczeye sahip grupta daha s\u0131k g\u00f6r\u00fclmekte ve bu hedeflenen grubun b\u00fct\u00e7e ay\u0131r\u0131p a\u015f\u0131ya ula\u015fabilmesi de ayr\u0131 bir sosyolojik problem olarak kar\u015f\u0131m\u0131za \u00e7\u0131kmaktad\u0131r.<\/p>\n\n\n\n

Tek doz HPV a\u015f\u0131s\u0131 rahim a\u011fz\u0131 kanserine kar\u015f\u0131 etkin midir?<\/strong><\/p>\n\n\n\n

A\u015f\u0131ya ula\u015fma g\u00fc\u00e7l\u00fc\u011f\u00fc ve y\u00fcksek a\u015f\u0131 maliyeti, tek doz a\u015f\u0131laman\u0131n sundu\u011fu ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n ara\u015ft\u0131r\u0131lmas\u0131 fikrini beraberinde getirdi ve Kenya\u2019da yap\u0131lan bir \u00e7al\u0131\u015fma neticesinde tek doz yap\u0131lan HPV a\u015f\u0131lamas\u0131n\u0131n etkin olabilece\u011fiyle ilgili bulgular ortaya \u00e7\u0131kt\u0131. Bu bilgiye istinaden DS\u00d6\u2019ye ba\u011fl\u0131 olarak \u00e7al\u0131\u015fan Stratejik Uzmanlar Dan\u0131\u015fma Grubu tek doz HPV a\u015f\u0131s\u0131n\u0131n etkin oldu\u011funu ve a\u015f\u0131 \u015femas\u0131n\u0131n bu duruma g\u00f6re yeniden d\u00fczenlenmesi gerekti\u011fine dair a\u00e7\u0131klamay\u0131 yapt\u0131.<\/p>\n\n\n\n

Bug\u00fcne kadar \u00f6nerilen ve yeni \u00f6nerilen HPV a\u015f\u0131 \u015femas\u0131 nas\u0131ld\u0131r?<\/strong><\/p>\n\n\n\n

Bu zamana kadar, rahim a\u011fz\u0131 kanserinden korunmak i\u00e7in kullan\u0131lan a\u015f\u0131 \u015femas\u0131:<\/p>\n\n\n\n